Titre :
  • Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib
Auteur : La Rosée, Paul P. ; Klag, Thomas T. ; Schenk, Thomas T. ; Hochhaus, Andreas A. ; Martiat, Philippe ; Leitner, Armin A. ; Muller, Martin M.J. ; Erben, Philipp P. ; Saussele, Susanne S.
Informations sur la publication : Annals of hematology, 92, 10, (page 1345-1350)
Statut de publication : Publié, 2013-10
Sujet CREF : Hématologie
Mots-clés : CML
Dasatinib
Dosing
Resistance
Tolerability
Toxicity
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Benzamides -- administration & dosage -- therapeutic use
Drug Administration Schedule
Drug Resistance, Neoplasm
Female
Humans
Leukemia, Myeloid, Chronic-Phase -- drug therapy
Male
Middle Aged
Piperazines -- administration & dosage -- therapeutic use
Pyrimidines -- administration & dosage -- therapeutic use
Retrospective Studies
Thiazoles -- administration & dosage -- therapeutic use
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0939-5555 
info:doi/10.1007/s00277-013-1769-2
info:pmid/23625298